The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
Code | Title | |
---|---|---|
M01AX01 | Nabumetone | |
M01AX02 | Niflumic acid | |
M01AX04 | Azapropazone | |
M01AX05 | Glucosamine | |
M01AX07 | Benzydamine | |
M01AX12 | Glucosaminoglycan polysulfate | |
M01AX13 | Proquazone | |
M01AX14 | Orgotein | |
M01AX17 | Nimesulide | |
M01AX18 | Feprazone | |
M01AX21 | Diacerein | |
M01AX22 | Morniflumate | |
M01AX23 | Tenidap | |
M01AX24 | Oxaceprol | |
M01AX25 | Chondroitin sulfate | |
M01AX26 | ||
M01AX68 | Feprazone, combinations |
Active Ingredient | Description | |
---|---|---|
Benzydamine |
Benzydamine exerts an anti-inflammatory and analgesic action by stabilising the cellular membrane and inhibiting prostaglandin synthesis. |
|
Chondroitin sulfate |
Chondroitin sulfate belongs to the polysaccharide subgroup of glycosaminoglycans. Chondroitin sulfate is one of the main elements of the cartilage, which joins a central protein, forming what we know as proteoglycan, which is what gives the cartilage its mechanical and elastic properties. |
|
Diacerein |
Diacerein is an anthraquinone derivative which has moderate anti-inflammatory activity. It is anti-inflammatory at high doses and devoid of any irritant effect on the stomach. |
|
Glucosamine |
Glucosamine is an endogenous substance, a normal constituent of the polysaccharide chains of cartilage matrix and synovial fluid glucosaminoglycans. In vitro and in vivo studies have shown glucosamine stimulates the synthesis of physiological glycosaminoglycans and proteoglycans by chondrocytes and of hyaluronic acid by synoviocytes. |
|
Nabumetone |
Nabumetone is a non acidic non steroidal anti-inflammatory agent with weak prostaglandin synthesis properties. Nabumetone undergoes rapid and extensive metabolism in the liver to 6-methoxy-2-naphthylacetic acid (6-MNA), the principal active metabolite which is a potent inhibitor of prostaglandin synthesis. |
|
Niflumic acid |
Niflumic acid is an analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis. |
|
Nimesulide |
Nimesulide is a non-steroidal anti-inflammatory drug with analgesic and antipyretic properties which acts as an inhibitor of prostaglandin synthesis enzyme cyclo-oxygenase. Cyclo-oxygenase produces prostaglandins, some of them being implicated in the development and maintenance of inflammation. |
|
Oxaceprol |
|
|
Soybean oil, refined |
|
Title | Information Source | Document Type | |
---|---|---|---|
APONIL Tablet | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
AULIN Gel | Health Products Regulatory Authority (IE) | MPI, EU: SmPC | |
CHONDROMEL Hard capsule | Health Products Regulatory Authority (IE) | MPI, EU: SmPC | |
DIFFLAM Lozenge | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
DOLENIO Film-coated tablets | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
MESULID Tablet | MPI, EU: SmPC | ||
NIMM Tablet | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
RELAFEN Tablet | FDA, National Drug Code (US) | MPI, US: SPL/Old |